The Novel Coronavirus Disease (COVID-19): A PRISMA Systematic Review and Meta-Analysis of Clinical and Paraclinical Characteristics

Table 2

Appraisal tool for cross-sectional studies (AXIS) scores of included studies.

Row	Author	Date	AXIS score						Reference
			Introduction	Methods	Results	Discussion	Others	Total
1	Fang et al.	Feb 19	1	6	4	2	2	15	[6]
2	Zhao et al.	Feb 18	1	8	3	2	2	16	[38]
3	Shi et al.	Feb 24	1	9	3	2	2	17	[40]
4	Pan et al.	Feb 13	1	7	2	2	2	14	[41]
5	Xu et al.	Feb 28	1	6	4	2	2	15	[42]
6	Zhang et al.	Mar 25	1	7	2	2	2	14	[43]
7	Chen et al.	Jan 30	1	8	5	2	2	18	[44]
8	Huang	Feb 21	1	8	5	2	2	18	[18]
9	Wu et al.	Feb 29	1	6	2	2	1	12	[19]
10	Guan et al.	Feb 28	1	9	5	2	2	19	[45]
11	Wang et al.	Feb 29	1	9	5	2	2	19	[46]
12	Yang et al.	Feb 26	1	5	3	2	2	13	[47]
13	Xu et al.	Feb 25	1	6	4	2	2	15	[48]
14	Wu et al.	Feb 29	1	9	3	2	2	17	[49]
15	Li et al.	Feb 29	1	8	5	2	2	18	[50]
16	Xia et al.	Mar 05	1	5	2	2	2	12	[51]
17	Zhang et al.	Feb 19	1	6	2	1	2	12	[52]
18	Zhou et al.	Feb 16	1	5	4	2	2	14	[53]
19	Wang et al.	Feb 24	1	7	3	2	2	15	[54]
20	Yoon et al.	Apr 21	1	4	3	2	2	12	[55]
21	Qian et al.	Feb 21	1	7	4	2	2	16	[56]
22	Liu et al.		1	6	4	2	2	15	[57]
23	Chen et al.		1	5	2	2	2	12	[58]
24	Young et al.	Feb 24	1	8	4	2	2	17	[59]
25	Fan et al.	Mar 05	1	8	3	2	2	16	[30]
29	Deng and Peng	Feb 14	1	5	5	2	2	15	[60]
32	Huang et al.	Feb 24	1	5	3	2	2	13	[61]
33	Kui et al.	Feb 07	1	5	3	2	2	13	[62]
34	Tian et al.	Feb 27	1	5	3	2	2	13	[63]
38	Xiao-Wei et al.	Feb 19	1	7	2	2	2	14	[64]